Macquarie Group’s Harte-Hanks HHS Stock Holding History

Macquarie Group’s Portfolio HHS Stock Details HHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-7,411	Closed	-$79K	–	2407
2017 Q3	$79K	Buy	+7,411	New	+$68.2K	﹤0.01%	1954

Other funds holding HHS

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return

VCA

VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return

EVC

Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Foundry Partners Minneapolis, Minnesota $1.89B AUM 9.84% 1-Year Est. Return

Macquarie Group's HHS Position: Q4 2017 in Review

Macquarie Group sold out of Harte-Hanks (HHS) in Q4 2017, closing a stake of 7,411 shares — an estimated $79K sold.

Macquarie Group first reported a position in HHS in Q3 2017 and held it in 1 quarter. The position peaked at $79K in Q3 2017. 48 funds tracked by Wall St. Rank hold HHS as of Q4 2017.

Macquarie Group reported no remaining Harte-Hanks position as of Q4 2017 after selling out during the quarter.
Macquarie Group sold 7,411 Harte-Hanks shares in Q4 2017, an estimated $79K.
Macquarie Group first reported a position in Harte-Hanks in Q3 2017 and held it in 1 quarter.
Macquarie Group's Harte-Hanks position peaked at $79K in Q3 2017.
48 funds tracked by Wall St. Rank held Harte-Hanks as of Q4 2017.

Based on Macquarie Group's 13F filing for Q4 2017, filed 15 Feb 2018.